Product category:
Chemical analysis equipment
News Release from: RTI International | Subject: DuBiotech
Edited by the Laboratorytalk Editorial
Team on 10 February 2006
Scientific standards for Middle East
biotech park
Dubai Biotechnology and Research Park choses RTI International to develop scientific and regulatory standards that will be used to advance biotechnology research and development across the Middle East
The Dubai Biotechnology and Research Park (DuBiotech), the first park of its kind in the Middle East, is designed to be the centre of excellence in biotechnology that will link government, academia and industry through national and international collaboration to develop new technologies and products to address regional health and environmental issues "We're excited to be helping an organisation like DuBiotech set the stage for world-class research and development," said Adam Saffer, executive vice president of strategic planning at RTI
This article was originally published on Laboratorytalk on 9 Feb 2006 at 8.00am (UK)
Related stories
Polymer membranes lower hydrogen purification cost
Researchers at University of Texas at Austin and RTI International discover polymer membranes for producing hydrogen that bring energy-efficient low-cost hydrogen purification process a step closer
Treatment is cost-effective alternative to prison
Diverting drug offenders to treatment programmes rather than prison could save the US criminal justice system millions of dollars and reduce recidivism, according to a study by RTI International
"As the founding tenant of the Research Triangle Park, we're looking forward to the opportunity to share our knowledge and expertise to help establish DuBiotech as one of the leading research and development zones in the Middle East".
Under the one-year contract, RTI will define the appropriate laboratory and operational standards required to meet the unique characteristics of Dubai and DuBiotech.
RTI will work with DuBiotech to establish operational criteria and practices for the life science regulatory sectors that meet internationally recognised standards and best practices.
Further reading
RTI to study graduate student enrolments
RTI International has been awarded a contract with the US National Science Foundation to assess graduate student enrollments in science, engineering and health-related fields
Concern over differences in genetic databases
Growth of genomic information has led to increase in the number of databases and an increasing number of inconsistencies among data, decreasing the reliability of information when datasets are merged
Testing protocols to identify endocrine disruptors
RTI researchers assist US EPA to develop and standardise tests to screen pesticides and environmental contaminants for potential to cause developmental and reproductive problems in humans and animals
The framework will be benchmarked against those used for research parks worldwide, including in the European Union, United Kingdom, Canada, Singapore, Japan and the United States.
"DuBiotech's intent is to be recognised as a world class biotechnology research and technology park," said Terry Pierson, vice president of environmental sciences at RTI.
"We will be working with DuBiotech to establish a regulatory framework for health and safety, environmental management and laboratory operations, based on internationally accepted standards and practices".
The legal and regulatory framework will address general park regulations, health and safety issues, laboratory accreditation, environmental/waste management, bioethics, clinical trials, clinical and nonclinical research, as well as intellectual property concerns.
RTI also will ensure that the recommended legal and regulatory framework complies with both United Arab Emirates and Islamic laws and customs.
The Park will be located in the new economic development centre that includes prestigious projects like Dubailand and Dubai Outsource Zone.
DuBiotech plans for companies to begin moving operations into the park by the end of 2006.
Announced in February 2005, the Dubai Biotechnology and Research Park (DuBiotech) is a science and business park dedicated to the biotech industry, set within a free zone infrastructure.
DuBiotech has two main areas of interest.
The first is the Foundation for Research and Innovation (FRI) which will be the main arm focusing on government-funded R+D.
The FRI will initially focus on medical research and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech and equine-related biotechnology.
Other areas include drug discovery, stem cell research, infectious diseases and forensic research.
The second arm of DuBiotech aims to set up a biotechnology industry cluster with the appropriate infrastructure, facilities and service for incubators, R+D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organisations from other sectors in the industry.
DuBiotech is advised by an independent steering committee on scientific, business and ethical matters.
• RTI International: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
